Table 2.
Disorder | Treatment |
---|---|
Infection (viral, bacterial, spirochete, parasite) | Antimicrobials |
Galactosemia | Galactose-free diet |
Tyrosinemia type 1 | NTBC (2-(2- nitro-4-trifluoromethylbenzol)-1,3-cyclohexanedione), low tyrosine or phenylalanine diet |
Hereditary fructose intolerance | Fructose or sucrose free diet |
Hypothyroidism | Thyroid hormone replacement |
Cystic fibrosis | Pancreatic enzymes |
Hypopituitarism | Thyroid, growth hormone, cortisol replacement |
Bile acid synthesis defects | Cholic acid or ursodeoxycholic acid supplementation |
Biliary atresia | Hepatoportoenterostomy (Kasai procedure) |
Choledochal cyst | Mucosectomy and Choledochoenterostomy |
Spontaneous perforation of the common bile duct | Surgical drainage |
Inspissated bile, common bile duct stone | Biliary tract irrigation |
Parenteral nutrition associated cholestasis (intestinal failure associated cholestasis) | Intravenous lipid emulsion modification, advance enteral feedings |
Adapted from Feldman AG, Sokol RJ, Nat Rev Gastroenterol Hepatol, 2019: Table 153